KLRK1 and neoplasm: Down-regulation of β-catenin increased the expression of NKG2D ligands and decreased the expression of inhibitory MHC class I molecules, such as H-2L and H-2K2, in tumor cells, which triggered NK cell-mediated tumor rejection.